Lonza and Engitix Forge Strategic Alliance to Pioneer ECM-Targeted Antibody-Drug Conjugates
In a significant move that bridges the gap between extracellular matrix (ECM) biology and advanced bioconjugation chemistry, Lonza and Engitix...
antibody
The Precision Frontier: Navigating the Complex Analytical Landscape of Antibody-Drug Conjugate Development
In the rapidly evolving theatre of oncology, few modalities have garnered as much clinical excitement as antibody-drug conjugates (ADCs). Often...
Breaking the Henipavirus Barrier: A Breakthrough Antibody Cocktail Against Nipah and Hendra Viruses
In the ongoing global effort to fortify defenses against emerging zoonotic threats, a team of researchers at the Icahn School...
